Literature DB >> 18360746

Leukemic transformation of Langerhans cell sarcoma.

Kousuke Sumida1, Yuya Yoshidomi1, Hiroko Koga1, Nobuo Kuwahara1, Eijo Matsuishi1, Kennosuke Karube2, Koichi Oshima2, Hisashi Gondo3.   

Abstract

A 57-year-old man became aware of left supraclavicular lymph node swelling, which was subsequently diagnosed as Langerhans cell sarcoma, based on a positive immunophenotype for CD1a, S-100 protein, and langerin, and histologically bizarre pleomorphism. The tumor became leukemic 3 months later. Despite intensive chemotherapy, he died of disease progression 7 months after the initial diagnosis. Tumor cells in the leukemic phase expressed CD5, CD7, CD13, CD33, CD34, CD68, and CD123. These findings suggested leukemic transformation from Langerhans cell sarcoma. Leukemic transformation may be a clinical manifestation of advanced Langerhans cell sarcoma, and should be differentiated from acute myelogenous leukemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360746     DOI: 10.1007/s12185-008-0063-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

1.  Malignant histiocytosis with eosinophilia.

Authors:  D W Henderson; R E Sage
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

2.  Malignant histiocytosis: a case of generalized histiocytosis with infiltration of Langerhans' granule-containing histiocytes.

Authors:  M Imamura; S Sakamoto; H Hanazono
Journal:  Cancer       Date:  1971-08       Impact factor: 6.860

3.  Results of treatment of 127 patients with systemic histiocytosis.

Authors:  J S Greenberger; A C Crocker; G Vawter; N Jaffe; J R Cassady
Journal:  Medicine (Baltimore)       Date:  1981-09       Impact factor: 1.889

Review 4.  Cutaneous Langerhans cell sarcoma: a case report and review of the literature.

Authors:  Olga L Bohn; Guillermo Ruiz-Argüelles; Leticia Navarro; Jesus Saldivar; Sergio Sanchez-Sosa
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

5.  CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases.

Authors:  Takakazu Kawase; Minoru Hamazaki; Michinori Ogura; Yoshiaki Kawase; Toshihiko Murayama; Yoshio Mori; Hirokazu Nagai; Masatoshi Tateno; Takashi Oyama; Yoshikazu Kamiya; Hirofumi Taji; Yoshitoyo Kagami; Tomoki Naoe; Toshitada Takahashi; Yasuo Morishima; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

6.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Authors:  S A Pileri; T M Grogan; N L Harris; P Banks; E Campo; J K C Chan; R D Favera; G Delsol; C De Wolf-Peeters; B Falini; R D Gascoyne; P Gaulard; K C Gatter; P G Isaacson; E S Jaffe; P Kluin; D M Knowles; D Y Mason; S Mori; H-K Müller-Hermelink; M A Piris; E Ralfkiaer; H Stein; I-J Su; R A Warnke; L M Weiss
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

7.  Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report.

Authors:  Jong-Sil Lee; Gyung Hyuck Ko; Ho Cheol Kim; In Seok Jang; Kyung-Nyeo Jeon; Jeong-Hee Lee
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

8.  GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.

Authors:  C Caux; C Dezutter-Dambuyant; D Schmitt; J Banchereau
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

9.  Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells.

Authors:  C Caux; B Vanbervliet; C Massacrier; I Durand; J Banchereau
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

10.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.

Authors:  C Caux; B Vanbervliet; C Massacrier; C Dezutter-Dambuyant; B de Saint-Vis; C Jacquet; K Yoneda; S Imamura; D Schmitt; J Banchereau
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  6 in total

1.  Langerhans cell sarcoma: Response to radiotherapy.

Authors:  Anna Lucas; Eva González Barca; Octavio Servitje; Lina Abenoza; María Noel González; Miquel Macià; Alicia Lozano
Journal:  Rep Pract Oncol Radiother       Date:  2010-07-06

2.  Langerhans Cell Sarcoma of the Axillary Lymph Node: A Case Report and Review of the Literature.

Authors:  Aylin Orgen Çallı; Yelda Morgül; İnci Alacacıoğlu; Sadi Bener; Bahriye Payzin
Journal:  Turk J Haematol       Date:  2013-06-05       Impact factor: 1.831

3.  Langerhans cell sarcoma originating from left knee subcutaneous tissue: A case report and literature review.

Authors:  Yaonan Zhang; Zongyang Qu; Fang Fang
Journal:  Oncol Lett       Date:  2016-09-27       Impact factor: 2.967

4.  Differential Diagnosis of Rare Diseases Involving Bilateral Lower Extremities with Similar 99mTc-MDP Bone Scan Patterns: Analysis of a Case Series.

Authors:  Zhenkui Sun; Chentian Shen
Journal:  Diagnostics (Basel)       Date:  2022-04-06

Review 5.  Multifocal Langerhans cell sarcoma involving epidermis: a case report and review.

Authors:  Changsong Wang; Yanping Chen; Chunfang Gao; Jian Yin; Hong Li
Journal:  Diagn Pathol       Date:  2012-08-14       Impact factor: 2.644

6.  Epstein-Barr Virus-Positive Langerhans Cell Sarcoma: Is There a Link? A Case Report.

Authors:  Yu Guo; Shui-Hong Zhou; Zai-Zai Cao; Yang-Yang Bao; Li-Fang Shen; Hong-Tian Yao
Journal:  Front Oncol       Date:  2022-01-18       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.